Additive manufacturing and 3D printing technology have a lot to offer makers of biomedical devices. [ + ]

The Global Alliance for Genomics and Health has announced a new application programming interface that will allow DNA data providers and consumers to better share information and work together on a global scale. [ + ]

Phosphagenics (ASX:POH) achieved encouraging results from the first of two planned IND-enabling phase I trials of pain patch TPM/oxymorphone. [ + ]

Scientists from IBM have unveiled the first neurosynaptic computer chip to achieve an unprecedented scale of 1 million programmable spiking neurons, 256 million programmable synapses and 46 billion synaptic operations per second per watt. [ + ]

Clinuvel (ASX:CUV) has declined a takeover bid from US-based Retrophin, with the board electing to focus the company's efforts on pursuing EMA approval for Scenesse in skin condition EPP. [ + ]

Professor Mark Hogarth has spent most of his career studying the role of Fc receptors in inflammatory and auto-immune disorders. Found on the surface of a variety of immune cells, these antibody-binding receptors are now prospective targets for new treatments of inflammation, therapeutic monoclonal antibodies in cancer and manipulation in vaccines for HIV-AIDS. [ + ]

The Australian Private Equity and Venture Capital Association has provided a submission to the Senate Economics References Committee's inquiry into Australia's innovation system, claiming Australia is in urgent need of a new national innovation policy to ensure we have a highly dynamic and modern economy in the future. [ + ]

X-ray tube supplier AXT has been competitively selected to provide a Tescan Integrated Minerals Analyser (TIMA) to the John de Laeter Centre (JDLC) at Curtin University in Western Australia. [ + ]

Cochlear (ASX:COH) grew its 2H14 profit by 32% and sales by 28% as the company launched new additions to each of its product categories. [ + ]

Pharmaxis (ASX:PXS) is taking NovaQuest to court, seeking a reinstatement of the US$40 million financing arrangement covering commercialisation of Bronchitol in the EU and US. [ + ]

The European Society For Medical Oncology (ESMO) has expressed concern that the proposed EU General Data Protection Regulation could make cancer research impossible and add a significant burden to both doctors and cancer patients. [ + ]

A passionate advocate for science, Professor Lyn Beazley shares some of the exceptional and continuing contributions she has made to Australian science over a career that began with a passion for biology. [ + ]

Researchers from UTS have developed a fast and easy way to administer a blood test for detecting early warning signs of oral cancers. [ + ]

A German court has issued an injunction prohibiting Taiwan's APEX Medical from local sales of two face masks found to infringe on ResMed (ASX:RMD) patents. [ + ]

Patrys (ASX:PAB) has started collaborative research into genetically engineering T cells against novel anticancer targets using its IgM antibodies. [ + ]